Protein binding and signaling properties of RIN1 suggest a unique effector function.

Human RIN1 was first characterized as a RAS binding protein based on the properties of its carboxyl-terminal domain. We now show that full-length RIN1 interacts with activated RAS in mammalian cells and defines a minimum region of 434 aa required for efficient RAS binding. RIN1 interacts with the "effector domain" of RAS and employs some RAS determinants that are common to, and others that are distinct from, those required for the binding of RAF1, a known RAS effector. The same domain of RIN1 that binds RAS also interacts with 14-3-3 proteins, extending the similarity between RIN1 and other RAS effectors. When expressed in mammalian cells, the RAS binding domain of RIN1 can act as a dominant negative signal transduction blocker. The amino-terminal domain of RIN1 contains a proline-rich sequence similar to consensus Src homology 3 (SH3) binding regions. This RIN1 sequence shows preferential binding to the ABL-SH3 domain in vitro. Moreover, the amino-terminal domain of RIN1 directly associates with, and is tyrosine phosphorylated by, c-ABL. In addition, RIN1 encodes a functional SH2 domain that has the potential to activate downstream signals. These data suggest that RIN1 is able to mediate multiple signals. A differential pattern of expression and alternate splicing indicate several levels of RIN1 regulation.

[1]  P. J. Belshaw,et al.  Oligomerization activates c-Raf-1 through a Ras-dependent mechanism , 1996, Nature.

[2]  M. Wigler,et al.  A Role for the Ral Guanine Nucleotide Dissociation Stimulator in Mediating Ras-induced Transformation* , 1996, The Journal of Biological Chemistry.

[3]  M. Wigler,et al.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[4]  C. Der,et al.  Peptides containing a consensus Ras binding sequence from Raf-1 and theGTPase activating protein NF1 inhibit Ras function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Wigler,et al.  Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RAS , 1996, Science.

[6]  H. Herschman,et al.  v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.

[7]  T. Mustelin,et al.  Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Roussel,et al.  Signaling by ABL oncogenes through cyclin D1. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. McCormick,et al.  Bcr and Raf form a complex in vivo via 14‐3‐3 proteins. , 1995, The EMBO journal.

[10]  P. Laneuville.  Abl tyrosine protein kinase. , 1995, Seminars in immunology.

[11]  D. Morrison,et al.  Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro , 1995, Molecular and cellular biology.

[12]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[13]  R. Sternglanz,et al.  Identification of a new family of tissue-specific basic helix-loop-helix proteins with a two-hybrid system , 1995, Molecular and cellular biology.

[14]  A. Wittinghofer,et al.  The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with RaplA and a GTP analogue , 1995, Nature.

[15]  C. Der,et al.  Two Distinct Raf Domains Mediate Interaction with Ras (*) , 1995, The Journal of Biological Chemistry.

[16]  J. Colicelli,et al.  A human protein selected for interference with Ras function interacts directly with Ras and competes with Raf1 , 1995, Molecular and cellular biology.

[17]  M. Wigler,et al.  Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.

[18]  J. Bischoff,et al.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Maruta,et al.  The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. , 1994, The Journal of biological chemistry.

[20]  R. Rickles,et al.  Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. , 1994, The EMBO journal.

[21]  S. Fields,et al.  Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  D. Baltimore,et al.  SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. , 1994, Trends in biochemical sciences.

[23]  S. Demo,et al.  ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.

[24]  W. Fantl,et al.  Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.

[25]  H. Fu,et al.  Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family. , 1994, Science.

[26]  Sushovan Guha,et al.  The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest , 1994, Cell.

[27]  H. Herschman,et al.  v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element , 1994, Molecular and cellular biology.

[28]  K. Irie,et al.  Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. , 1994, Science.

[29]  F. McCormick,et al.  Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. , 1994, Science.

[30]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[31]  S. Fields,et al.  The two-hybrid system: an assay for protein-protein interactions. , 1994, Trends in genetics : TIG.

[32]  M. Nakafuku,et al.  GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[34]  F. McCormick,et al.  Structural requirements for the interaction of p21ras with GAP, exchange factors, and its biological effector target. , 1993, The Journal of biological chemistry.

[35]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[36]  D. Baltimore,et al.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.

[37]  F. McCormick,et al.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Wigler,et al.  Expression of three mammalian cDNAs that interfere with RAS function in Saccharomyces cerevisiae. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Cooper,et al.  Effect of a dominant inhibitory Ha-ras mutation on mitogenic signal transduction in NIH 3T3 cells , 1990, Molecular and cellular biology.

[40]  W. Kabsch,et al.  Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.

[41]  D. Baltimore,et al.  The mouse type IV c-abl gene product is a nuclear protein, and activation of transforming ability is associated with cytoplasmic localization , 1989, Cell.

[42]  S H Kim,et al.  Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. , 1988, Science.

[43]  D. Melton,et al.  Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs. , 1984, Nucleic acids research.

[44]  R. Finney,et al.  Ras-Raf complexes: analyses of complexes formed in vivo. , 1995, Methods in enzymology.

[45]  C. Der,et al.  Biological assays for cellular transformation. , 1994, Methods in enzymology.